Seer.cancer.gov/seerstat prostate cancer incidence and mortality rates, racial differences, 1976–2022

Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, Falagario UG, Liu Y, Davicioni E, Spratt DE, Schaeffer EM, Feng FY, Mahal B, Nguyen PL, Den RB, Greenberger MD, Bradley R, Watson JM, Beamer M, Stamatakis L, Carmen DJ, Awasthi S, Hwang J, Weil R, Merisaari H, Mohamed N, Deane LA, Chakravarty D, Yadav KK, Yamoah K, Nair SS, Tewari AK. (2021) Commun Biol. 4(1):670. https://doi.org/10.1038/s42003-021-02140-y

Tsion Zewdu Minas # 1, Julián Candia # 1 2, Tiffany H Dorsey 1, Francine Baker 1, Wei Tang 1, Maeve Kiely 1, Cheryl J Smith 1, Amy L Zhang 1, Symone V Jordan 1, Obadi M Obadi 1, Anuoluwapo Ajao 1, Yao Tettey 3, Richard B Biritwum 3, Andrew A Adjei 3, James E Mensah 3, Robert N Hoover 4, Frank J Jenkins 5, Rick Kittles 6, Ann W Hsing 7 8, Xin W Wang 1 9, Christopher A Loffredo 10, Clayton Yates 11, Michael B Cook 4, Stefan Ambs 12-Nat Commun 2022 Apr 1;13(1):1759 https://doi.org/10.1038/s41467-022-29235-2.

Sartor, O. (2020). Andrew J Armstrong, Chiledum Ahaghotu, David G McLeod, Matthew R Cooperberg, David F Penson, Philip W Kantoff, Nicholas J Vogelzang, Arif Hussain, Christopher M Pieczonka, Neal D Shore, David Quinn, Eric J Small, Elisabeth I Heath, Ronald F Tutrone, Paul F Schellhammer, Matthew Harmon, Nancy N Chang, Nadeem A Sheikh, Bruce Brown, Stephen J Freedland, Celestia S Higano. Prostate Cancer and Prostatic Diseases, 23(3), 517–526. https://doi.org/10.1038/s41391-020-0213-7

Article  PubMed  PubMed Central  Google Scholar 

Shigdar, S., Li, Y., Bhattacharya, S., O’Connor, M., Pu, C., Lin, J., Wang, T., Xiang, D., Kong, L., Wei, M. Q., Zhu, Y., Zhou, S., & Duan, W. (2014). Inflammation and cancer stem cells. Cancer Letters, 345(2), 271–278.

Article  PubMed  Google Scholar 

Korkaya, H., Liu, S., & Wicha, M. S. (2011). Regulation of cancer stem cells by cytokine networks: Attacking cancer’s inflammatory roots. Clinical Cancer Research, 17(19), 6125–6129. https://doi.org/10.1158/1078-0432.CCR-10-2743

Article  PubMed  PubMed Central  Google Scholar 

Powell, I. J., Dyson, G., Land, S., Ruterbusch, J., Bock, C. H., Lenk, S., Herawi, M., Everson, R., Giroux, C. N., Schwartz, A. G., & Bollig-Fischer, A. (2013). Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer epidemiology, biomarkers & prevention : A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22(5), 891–897. https://doi.org/10.1158/1055-9965.EPI-12-1238

Article  Google Scholar 

Powell, I. J., Chinni, S. R., Reddy, S. S., Zaslavsky, A., & Gavande, N. (2021). Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update. Urologic Oncology, 39(1), 34–40. https://doi.org/10.1016/j.urolonc.2020.08.019

Article  PubMed  Google Scholar 

Cao, Z., & Kyprianou, N. (2015). Mechanisms navigating the TGF-beta pathway in prostate cancer. Asian Journal of Urology, 2, 11–18.

Article  PubMed  PubMed Central  Google Scholar 

Mughees, M., Kaushal, J. B., Sharma, G., Wajid, S., Batra, S. K., & Siddiqui, J. A. (2022). Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis. Seminars in Cancer Biology, 86(Pt 3), 497–512. https://doi.org/10.1016/j.semcancer.2022.02.017

Article  PubMed  PubMed Central  Google Scholar 

Tsai, C. Y., Lee, T. S., Kou, Y. R., & Wu, Y. L. (2009). Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation. Journal of Cellular Biochemistry, 108, 489–498.

Article  PubMed  Google Scholar 

Waugh, D. J., & Wilson, C. (2008). The interleukin-8 pathway in cancer. Clinical Cancer Research, 14, 6735–6741.

Article  PubMed  Google Scholar 

Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., et al. (2009). NF-kappaB regulates androgen receptor expression and prostate cancer growth. American Journal of Pathology, 175, 489–499.

Article  PubMed  PubMed Central  Google Scholar 

Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., et al. (2008). Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Research, 68, 4606–4613.

Article  PubMed  PubMed Central  Google Scholar 

Kim, J. H., Jeong, J. H., Jeon, S. T., Kim, H., Ock, J., Suk, K., et al. (2006). Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Molecular Pharmacology, 69, 1783–1790.

Article  PubMed  Google Scholar 

Luo, J., Lee, S. O., Cui, Y., Yang, R., Li, L., & Chang, C. (2015). Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2alpha/androgen receptor signals. Oncotarget, 6, 27555–27565.

Article  PubMed  PubMed Central  Google Scholar 

Deng, S., Wang, C., Wang, Y., et al. (2022). Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nature Cancer, 3, 1071–1087. https://doi.org/10.1038/s43018-022-00431-9

Article  PubMed  PubMed Central  Google Scholar 

Singh, N., Baby, D., Rajguru, J. P., Patil, P. B., Thakkannavar, S. S., & Pujari, V. B. (2019). Inflammation and cancer. Annals of African Medicine, 18(3), 121–126. https://doi.org/10.4103/aam.aam_56_18

Article  PubMed  PubMed Central  Google Scholar 

Grivennikov, S. I., & Karin, M. (2011). Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Annals of the Rheumatic Diseases, 70(Suppl 1), i104–i108. https://doi.org/10.1136/ard.2010.140145

Article  PubMed  Google Scholar 

Khandrika, L., Kumar, B., Koul, S., Maroni, P., & Koul, H. K. (2009). Oxidative stress in prostate cancer. Cancer Letters, 282(2), 125–136. https://doi.org/10.1016/j.canlet.2008.12.011

Article  PubMed  PubMed Central  Google Scholar 

Maynard, J. P., Ertunc, O., Kulac, I., Baena-Del Valle, J. A., De Marzo, A. M., & Sfanos, K. S. (2020). IL8 expression is associated with prostate cancer aggressiveness and androgen receptor loss in primary and metastatic prostate cancer. Molecular Cancer Research, 18(1), 153–165. https://doi.org/10.1158/1541-7786.MCR-19-0595

Article  PubMed  Google Scholar 

Liang, Y., Zhong, Z., Huang, Y., Deng, W., Cao, J., Tsao, G., Liu, Q., Pei, D., Kang, T., & Zeng, Y. X. (2010). Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. The Journal of Biological Chemistry, 285(7), 4931–4940.

Article  PubMed  Google Scholar 

Carrero, R., Cerrada, I., Lledó, E., Dopazo, J., García-García, F., Rubio, M. P., Trigueros, C., Dorronsoro, A., Ruiz-Sauri, A., Montero, J. A., & Sepúlveda, P. (2012). IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. Stem Cell Reviews and Reports, 8(3), 905–916. https://doi.org/10.1007/s12015-012-9364-9

Article  PubMed  Google Scholar 

Skvortsov, S., Skvortsova, I. I., Tang, D. G., & Dubrovska, A. (2018). Concise review: Prostate cancer stem cells: Current understanding. Stem Cells, 36(10), 1457–1474. https://doi.org/10.1002/stem.2859

Article  PubMed  Google Scholar 

Han, C., Wang, Z., Xu, Y., Chen, S., Han, Y., Li, L., Wang, M., & Jin, X. (2020). Roles of reactive oxygen species in biological behaviors of prostate cancer. BioMed Research International, 2020, 1269624. https://doi.org/10.1155/2020/1269624

Article  PubMed  PubMed Central  Google Scholar 

Lu, Y., Loh, Y. H., Li, H., Cesana, M., Ficarro, S. B., Parikh, J. R., Salomonis, N., Toh, C. X., Andreadis, S. T., Luckey, C. J., Collins, J. J., Daley, G. Q., & Marto, J. A. (2014). Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell Stem Cell., 15(1), 92–101. https://doi.org/10.1016/j.stem.2014.04.002

Article  PubMed  PubMed Central  Google Scholar 

Bao, B., Mitrea, C., Wijesinghe, P., Marchetti, L., Girsch, E., Farr, R. L., Boerner, J. L., Mohammad, R., Dyson, G., Terlecky, S. R., & Bollig-Fischer, A. (2017). Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Science and Reports, 10(7), 44125. https://doi.org/10.1038/srep44125.PMID:28281569;PMCID:PMC5345072

Article  Google Scholar 

Teslow, E. A., Bao, B., Dyson, G., Legendre, C., Mitrea, C., Sakr, W., Carpten, J. D., Powell, I., & Bollig-Fischer, A. (2018). Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type. African American PCa cells. Molecular oncology, 12(7), 1138–1152. https://doi.org/10.1002/1878-0261.12316

Article  PubMed  Google Scholar 

Bao B, Teslow EA, Mitrea C, Boerner JL, Dyson G, Bollig-Fischer A. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol Cancer Res. 2020 Dec;18(12):1803–1814. https://doi.org/10.1158/1541-7786.MCR-20-0359

Ayodeji, S. A., Bao, B., Teslow, E. A., Polin, L. A., Dyson, G., Bollig-Fischer, A., & Fehl, C. (2023). Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer. Cancer Cell International, 23(1), 102. https://doi.org/10.1186/s12935-023-02942-6.PMID:37231419;PMCID:PMC10210312

Article  PubMed  PubMed Central  Google Scholar 

Jin, F., Miao, Y., Xu, P., & Qiu, X. (2018). IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446. OncoTargets and Therapy, 11, 5723–5731. https://doi.org/10.2147/OTT.S161760

Article  PubMed  PubMed Central  Google Scholar